Correlation Between Apellis Pharmaceuticals and Morphic Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Morphic Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Morphic Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Morphic Holding, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Morphic Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Morphic Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Morphic Holding.

Diversification Opportunities for Apellis Pharmaceuticals and Morphic Holding

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Apellis and Morphic is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Morphic Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morphic Holding and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Morphic Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morphic Holding has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Morphic Holding go up and down completely randomly.

Pair Corralation between Apellis Pharmaceuticals and Morphic Holding

If you would invest  2,958  in Apellis Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of  442.00  from holding Apellis Pharmaceuticals or generate 14.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Apellis Pharmaceuticals  vs.  Morphic Holding

 Performance 
       Timeline  
Apellis Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apellis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Apellis Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Morphic Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Morphic Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Morphic Holding is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Apellis Pharmaceuticals and Morphic Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apellis Pharmaceuticals and Morphic Holding

The main advantage of trading using opposite Apellis Pharmaceuticals and Morphic Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Morphic Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morphic Holding will offset losses from the drop in Morphic Holding's long position.
The idea behind Apellis Pharmaceuticals and Morphic Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Share Portfolio
Track or share privately all of your investments from the convenience of any device